Sandra Schoebel is currently the Business Insights & Analytics Lead (Oncology) at AstraZeneca, focusing on hematology, gynecology, and breast cancer. From 2021 to 2023, they served as the EMEA Business Insights lead at Johnson & Johnson, contributing to brand positioning and strategy through integrated insights. Previously, they held the position of Associate Director at Bristol Myers Squibb from 2015 to 2021, leading global analytics initiatives. Sandra's career began at Kantar from 2004 to 2011, and they also worked at Novartis from 2012 to 2015.
This person is not in any teams
This person is not in any offices